An improper access control vulnerability may allow privilege escalation.This issue affects: * ELI 380 Resting Electrocardiograph: Versions 2.6.0 and prior; * ELI 280/BUR280/MLBUR 280 Resting Electrocardiograph: Versions 2.3.1 and prior; * ELI 250c/BUR 250c Resting Electrocardiograph: Versions 2.1.2 and prior; * ELI 150c/BUR 150c/MLBUR 150c Resting Electrocardiograph: Versions 2.2.0 and prior.
This vulnerability carries a HIGH severity rating with a CVSS v3.1 score of 7.7, indicating it can be exploited remotely over the network but requires specific conditions to be met without requiring user interaction requiring only low-level privileges . The vulnerability impacts limited data confidentiality, limited integrity, and availability (service disruption) for affected systems.
Reported in 2025, this vulnerability emerged during an era marked by increased sophistication in supply chain attacks, cloud infrastructure vulnerabilities, and software-as-a-service (SaaS) security challenges. Security practices during this period emphasized zero-trust architectures, container security, and API protection.
2025-02-07T17:15:22.130
2026-04-15T00:35:42.020
Deferred
CVSSv3.1: 7.7 (HIGH)
-
SecUtils normalizes and enriches National Vulnerability Database (NVD) records by standardizing vendor and product identifiers, aggregating vulnerability metadata from both NVD and MITRE sources, and providing structured context for security teams. For affected software, we extract Common Platform Enumeration (CPE) data, Common Weakness Enumeration (CWE) classifications, CVSS severity metrics, and reference data to enable rapid vulnerability prioritization and asset correlation. This record contains no exploit code, proof-of-concept instructions, or attack methodologies—only defensive intelligence necessary for patch management, risk assessment, and security operations.